Click here to see a list of our past events.
Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free, month-long NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills.
The May 8 to June 5 course is virtual and hosted by Cornell University. Application closes on Wednesday, April 10.
Register here.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to get answers to their intellectual property questions and gain more information about how to advance of their IP towards commercial partnership with a one-on-one meeting.
On Tuesday, April 16, from 2 – 4 pm, CTL is partnering with the Sanders Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) to answer WCM researchers’ questions about developing a novel therapeutic or drug.
If you have a potential therapeutic target and are looking for resources, don’t miss this opportunity! Tri-I TDI’s mission is to translate groundbreaking biological discoveries by Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University into novel small molecule or biologic therapeutics. It provides industry-quality technical support for academic projects, making it possible to rapidly assess the utility of specific therapeutics in disease-relevant contexts.
Reserve your 30-minute session here. You will be given access to a Zoom registration link and meet privately with a CTL business development professional and a representative from Tri-I TDI matching your area of interest.
Join us on Thursday, March 28th, from 12-1 pm EST for an enlightening session dedicated to the I-Corps program, a transformative National Science Foundation initiative that enables researchers to amplify the impact of their scientific discoveries in the marketplace. In honor of Women’s History Month, this event is tailor-made for the Equalize community and female academic entrepreneurs eager to explore the commercial viability of their innovations. Engage in discussions with panels featuring academic researchers and startups, sharing their customer discovery journeys within the I-Corps program. They will provide invaluable insights, enriching the event with their unique perspectives and expertise. Seize this exceptional opportunity to connect, learn, and make your mark within a thriving innovation and entrepreneurship ecosystem. Be part of this inspiring community event that celebrates and elevates women’s roles in pioneering change!
Female founders are bringing innovation, technology, medicine, wellness, and their own lived experiences together to advance women’s healthcare. Our Cornellian entrepreneurs will share their journeys starting women’s healthcare businesses, and how, through their companies and technologies, they’re addressing women’s unique needs and solving our most pressing health challenges. Join us to wrap up Women’s History Month with a look into the future!
Featuring:
- Andrea Ippolito ’06, MENG ’07, CEO & Founder, SimpliFed
- Eve McDavid, Cornell Tech Runway Post-doc Fall ’22 Cohort & CEO, Mission-Driven Tech
- J’Vanay Santos-Fabian MBA ’22, CEO & Co-Founder, MyLÚA Health
- Carolyn Witte ’12, CEO & Co-Founder, Tia
Calling all researchers! If you have been working on a technology innovation and wish to explore its commercialization potential, I-Corps can provide you with entrepreneurial education, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session on Tuesday, March 26 (12:00 – 12:45 p.m. ET) is designed for busy graduate students, postdocs, and faculty interested in learning more about I-Corps regional and national programming. I-Corps alumni Ruben Trujillo, a Ph.D. candidate at Cornell University, and Nancy Guo, a professor at West Virginia University and recent NSF SBIR awardee, will be in attendance to share their experiences and answer questions.
The National Science Foundation created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.
Register: https://bit.ly/ICorpsMarch24
Do you have ideas for a new medical device, but aren't sure where to begin with initial design? Interested in learning how to utilize 3D printing to create prototypes and get your idea started? Back by popular demand, the BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, is offering a second basic seminar in 3D printing.
Join us at the BioVenture eLab makerspace to learn how to use specialized software and Google Sketch to create designs for 3D printing.
The seminar will feature our guest lecturer, NatalieDeana Badillo, a third-year medical student at Weill Cornell Medicine who possesses a biomedical engineering background. Natalie is also a member of the Biomedical Engineering Society and is President of the Arts & Crafts & 3D Printing Club at Weill Cornell Medicine. Register now.
Applications Now Open for the BenDaniel Venture Challenge
The BenDaniel Venture Challenge (BVC) is Big Red Venture’s Annual Pitch Competition. BRV will select five finalists to pitch their business ideas to a panel of investors during Entrepreneurship at Cornell Celebration on April 12. Winners will earn a cash prize totaling $25,000 with an additional $25,000 match if the company’s technology is licensed through Cornell.
Companies based in New York state or with a Cornell affiliation are eligible to apply. Applications are open through March 22, 2024. Apply now.
Johnson & Johnson Innovation's annual JLABS Investor & Partnering Day will take place in New York City on Thursday, May 2, 2024, 8:30 am to 6 pm, and applications are now open for qualified, promising, early-stage biotech startups seeking pre-seed, seed, or series A funding in the next 12 to 18 months.
The day will consist of one-on-one matched meetings with strategically aligned life science investors, perspectives from experts including Johnson & Johnson Innovation – JJDC, Inc., a networking lunch, and a reception to provide additional opportunities to meet with investors and fellow biotech CEOs.
Please submit your application by March 22 and reach out to Miriam Huber if you have any questions. Note that there are limited spots available, so attendance is not guaranteed and is based on additional screening.
Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is proud to announce its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants (BRIDGe).
BRIDGe awards are designed to support academic researchers by providing funding and defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. Projects eligible for BRIDGe awards include early lead optimization and IND-enabling studies, using small molecule approaches, anywhere in the world. Biologicals, including peptides or antibodies, oligonucleotides, cell and gene therapy applications and medical devices are not eligible at this time. Drug repurposing approaches are also not eligible during this funding cycle.
Please see attached documents for the details of the funding opportunity and also a pre-proposal template. To apply, send Deanna Scarcella (des4016@med.cornell.edu) a NON-CONFIDENTIAL (make sure to EXCLUDE any unpublished data or information) pre-proposal by Friday, March 22, 2024, which will be reviewed by the CTL. CTL will coordinate submitting the pre-proposal by the deadline of Fri, Mar 29. Contact Deanna if you have any questions.
Join scientists from the Sanders Tri-Institutional Therapeutics Discovery Institute as they share their broad knowledge of small molecule and biologics drug discovery. This mini-course will be provided in four sessions over the course of three weeks (4/1, 4/2, 4/8 and 4/15). Classes will be structured informally with ample opportunity for questions and discussion.
The course covers:
- An overview of Sanders TDI
- Target identification and validation
- Assays for drug discovery
- Assay development
- Screening methodologies
- Introduction to medicinal chemistry
- Introduction to computational chemistry and molecular modeling
- Antibody generation strategies
- Immunization strategies
- Antibody engineering and optimization
- Developability assessment
The number of seats is limited. Register now. Questions? Contact Leigh Baxt at lbaxt@tritdi.org.